dehaze, a Munich-based healthtech AI company, raised 3.2 million EUR in a seed funding round led by YZR Capital and DN Capital, with participation from Angel Invest, Zoho, and Better Ventures. The company develops a foundational AI model for chronic disease detection using causal AI to analyse large volumes of patient data. The funding will support international demand, team expansion across engineering, research, and commercial functions, and further product and platform development, including next-best-action recommendations and traceability improvements.
About Dehaze
Healthtech startup developing an AI platform for the early detection of chronic diseases using existing health data such as lab values and diagnoses.
Munich, Germany
Read Company ProfileFrequently Asked Questions
What type of funding round did Dehaze raise?
Dehaze raised a seed round.
How much did Dehaze raise in its seed?
Dehaze raised $3,200,000 EUR in its seed.
When did Dehaze raise its seed?
Dehaze raised its seed on 2026-04-28.
Who invested in Dehaze's seed?
The investors in Dehaze's seed are: YZR Capital, DN Capital, Angel Invest, Zoho, better ventures.
What type of investment was Dehaze's seed?
Dehaze's seed was a equity investment.
How will Dehaze use the funds from its seed?
Dehaze plans to use the funds for: meet growing international demand, expand engineering team, expand research team, expand commercial team, accelerate product development, develop a foundational AI model for chronic disease detection, further develop platform capabilities, recommend next-best actions features, improve traceability.